Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/21957
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-09-14T13:20:31Z-
dc.date.available2021-09-14T13:20:31Z-
dc.date.issued2004-10-
dc.identifier.citationAvcı, R. vd. (2004). “Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema”. Graefes Archive for Clinical and Experimental Ophthalmology, 242(10), 845-852.en_US
dc.identifier.issn0721-832X-
dc.identifier.urihttps://doi.org/10.1007/s00417-004-0939-2-
dc.identifier.urihttps://link.springer.com/article/10.1007%2Fs00417-004-0939-2-
dc.identifier.urihttp://hdl.handle.net/11452/21957-
dc.description.abstractBackground: To evaluate the results of pars plana vitrectomy with peeling of the internal limiting membrane (ILM) in eyes with chronic macular oedema. Methods: PPV with indocyanine green (ICG) assisted peeling of the ILM was performed in 33 eyes with diabetic (21 eyes) or,non-diabetic (12 eyes) macular oedema. Postoperatively, resolution of macular oedema, improvement of visual acuity (VA) and complications were documented. The peeled membranes were submitted for light and transmission electron microscopic evaluation. Results: The mean follow-up time was 12.2 months. The macular oedema decreased or was resolved in 17 (81%) eyes in the diabetic group and in 11 (92%) eyes in the non-diabetic group. VA improved by at least 2 lines in 11 (52%) eyes in the diabetic group and in 7 (58%) eyes in the non-diabetic group. The difference between visual acuity improvements of the two groups was not statistically significant (P>0.05). However, in the diabetic group the difference of visual improvement between cystoid and diffuse type of macular oedema eyes was statistically significant (14% versus 71%, P=0.02). Light and transmission electron microscopy showed the presence of ILM in all specimens. During the follow-up period no recurrence of macular oedema or epiretinal membrane formation was observed. Conclusion: Pars plana vitrectomy with peeling of the ILM and epiretinal membrane leads to the resolution of macular oedema in the majority of eyes. This however, is not always associated with VA improvement. In diabetic eyes, cystoid type of macular oedema appears to be a poor prognostic factor for improved VA.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectOphthalmologyen_US
dc.subjectVascular-permeability factoren_US
dc.subjectRetinal vein occlusionen_US
dc.subjectEndothelial growth-factoren_US
dc.subjectIndocyanine-greenen_US
dc.subjectHoleen_US
dc.subjectSurgeryen_US
dc.subjectDamageen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshBasement membraneen_US
dc.subject.meshChronic diseaseen_US
dc.subject.meshColoring agentsen_US
dc.subject.meshDiabetic retinopathyen_US
dc.subject.meshEpiretinal membraneen_US
dc.subject.meshFemaleen_US
dc.subject.meshFluorescein angiographyen_US
dc.subject.meshHumansen_US
dc.subject.meshIndocyanine greenen_US
dc.subject.meshMacular edema, cystoiden_US
dc.subject.meshMaletr_TR
dc.subject.meshMiddle ageden_US
dc.subject.meshProspective studiesen_US
dc.subject.meshVisual acuityen_US
dc.subject.meshVitrectomyen_US
dc.titlePars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedemaen_US
dc.typeArticleen_US
dc.identifier.wos000225104800006tr_TR
dc.identifier.scopus2-s2.0-8444227790tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Göz Hastalıkları Anabilim Dalı.tr_TR
dc.identifier.startpage845tr_TR
dc.identifier.endpage852tr_TR
dc.identifier.volume242tr_TR
dc.identifier.issue10tr_TR
dc.relation.journalGraefes Archive for Clinical and Experimental Ophthalmologyen_US
dc.contributor.buuauthorAvcı, Remzi-
dc.contributor.buuauthorKaderli, Berkant-
dc.contributor.buuauthorAvcı, Berrin-
dc.contributor.buuauthorŞimşek, Şaban A.-
dc.contributor.buuauthorBaykara, Mehmet-
dc.contributor.buuauthorKahveci, Zeynep-
dc.contributor.buuauthorGelişken, Öner-
dc.contributor.buuauthorYücel, Ahmet Ali-
dc.contributor.researcheridABE-6685-2020tr_TR
dc.identifier.pubmed15221309tr_TR
dc.subject.wosOphthalmologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ2en_US
dc.contributor.scopusid7004838001tr_TR
dc.contributor.scopusid6507602756tr_TR
dc.contributor.scopusid6603017388tr_TR
dc.contributor.scopusid35557651300tr_TR
dc.contributor.scopusid6602526353tr_TR
dc.contributor.scopusid7005217049tr_TR
dc.contributor.scopusid23093006700tr_TR
dc.contributor.scopusid6603395784tr_TR
dc.subject.scopusMacular Edema; Ranibizumab; Laser Coagulationen_US
dc.subject.emtreeIndocyanine greenen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeCiliary disken_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeClinical observationen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDiabetic retinopathyen_US
dc.subject.emtreeDisease classificationen_US
dc.subject.emtreeEpiretinal membraneen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHistopathologyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMedical documentationen_US
dc.subject.emtreeOutcomes researchen_US
dc.subject.emtreePostoperative complicationen_US
dc.subject.emtreePostoperative perioden_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePrognosisen_US
dc.subject.emtreeRecurrent diseaseen_US
dc.subject.emtreeRetina macula cystoid edemaen_US
dc.subject.emtreeRetina macula edemaen_US
dc.subject.emtreeStatistical significanceen_US
dc.subject.emtreeSurgical approachen_US
dc.subject.emtreeTransmission electron microscopyen_US
dc.subject.emtreeTreatment planningen_US
dc.subject.emtreeVisual acuityen_US
dc.subject.emtreeVitrectomyen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons